Obstet Gynecol Sci.  2023 Sep;66(5):455-456. 10.5468/ogs.23145.

Nomograms to predict overall survival for patients with endometrial carcinosarcoma

• Iavazzo C
• Fotiou A
• Kokkali K
• Vrachnis N

• KMID: 2545892
• DOI: http://doi.org/10.5468/ogs.23145

Reference

References

1. Nanthamongkolkul K, Taweerat P, Jiamset I. A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand. Obstet Gynecol Sci. 2023; 66:198–207.

2. Chen M, He X, Yang Q, Zhang J, Peng J, Wang D, et al. Epidemiology and prediction model of patients with carcinosarcoma in the United States. Front Public Health. 2022; 10:1038211.

3. Liu Y, Lin X, Xue L, Wen Y, Wang S, Wang X. Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma. Transl Cancer Res. 2022; 11:52–62.

4. Gao L, Lyu J, Luo X, Zhang D, Jiang G, Zhang X, et al. Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery. BMC Cancer. 2021; 21:1149.